US Stock MarketDetailed Quotes

SYRA Syra Health

Watchlist
  • 0.391
  • +0.002+0.59%
Close Oct 4 16:00 ET
  • 0.391
  • 0.0000.00%
Post 18:13 ET
5.51MMarket Cap-1314P/E (TTM)

Syra Health Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
101.14%1.97M
47.46%1.75M
-1.83%5.52M
-10.15%1.77M
4.45%1.58M
-17.89%979.25K
25.71%1.19M
298.43%5.62M
1.97M
1.51M
Operating revenue
101.14%1.97M
47.46%1.75M
-1.83%5.52M
-10.15%1.77M
4.45%1.58M
-17.89%979.25K
25.71%1.19M
298.43%5.62M
--1.97M
--1.51M
Cost of revenue
90.31%1.62M
51.08%1.57M
-9.94%4.1M
-29.29%1.18M
-6.67%1.03M
-21.42%851.09K
49.19%1.04M
365.07%4.56M
1.67M
1.1M
Gross profit
173.10%350.01K
21.83%179.29K
32.97%1.41M
100.05%582.04K
34.01%554.54K
16.97%128.16K
-40.53%147.16K
146.72%1.06M
290.95K
413.81K
Operating expense
90.81%1.74M
76.13%1.62M
36.43%4.3M
75.87%1.57M
18.01%897.56K
24.70%912.11K
20.04%921.63K
626.76%3.15M
891.7K
760.6K
Selling and administrative expenses
60.60%1.45M
46.52%1.33M
29.02%4.01M
50.35%1.32M
17.74%885.2K
23.12%899.82K
18.56%909.87K
646.59%3.11M
--875.13K
--751.85K
-Selling and marketing expense
1,469.83%13.89K
1,669.39%15.38K
----
----
----
--885
--869
----
----
----
-General and administrative expense
59.21%1.43M
44.97%1.32M
29.02%4.01M
50.35%1.32M
17.74%885.2K
23.00%898.94K
18.45%909K
646.59%3.11M
--875.13K
--751.85K
Research and development costs
--277.89K
--277.55K
--240.05K
----
----
--0
--0
--0
----
----
Depreciation amortization depletion
41.33%17.37K
6.65%12.55K
228.45%48.77K
22.87%12.36K
218.48%12.36K
1,962.58%12.29K
3,634.29%11.76K
7,073.43%14.85K
--10.06K
--3.88K
-Depreciation and amortization
41.33%17.37K
6.65%12.55K
228.45%48.77K
22.87%12.36K
218.48%12.36K
1,962.58%12.29K
3,634.29%11.76K
7,073.43%14.85K
--10.06K
--3.88K
Other operating expenses
----
----
-89.04%3.37K
-99.23%50
----
----
----
76.47%30.74K
--6.51K
--4.87K
Operating profit
-77.35%-1.39M
-86.44%-1.44M
-38.18%-2.89M
-64.15%-986.15K
1.09%-343.02K
-26.06%-783.95K
-48.86%-774.48K
-63,610.21%-2.09M
-600.75K
-346.79K
Net non-operating interest income expense
100.51%97
72.88%-3.1K
-78.24%-50.74K
23.24%-9.12K
-46.69%-11.36K
-240.36%-18.85K
-245.34%-11.42K
-28.47K
-11.88K
-7.74K
Non-operating interest income
95,550.00%3.83K
48,950.00%981
4,569.84%2.94K
1,188.89%116
7,957.14%2.82K
-78.95%4
--2
--63
--9
--35
Non-operating interest expense
-80.22%3.73K
-64.30%4.08K
88.15%53.69K
-22.33%9.24K
82.29%14.18K
239.27%18.85K
245.40%11.42K
--28.53K
--11.89K
--7.78K
Other net income (expense)
Income before tax
-73.18%-1.39M
-84.13%-1.45M
-38.72%-2.94M
-62.46%-995.28K
0.04%-354.38K
-27.95%-802.8K
-50.10%-785.89K
-64,478.20%-2.12M
-612.63K
-354.54K
Income tax
Net income
-73.18%-1.39M
-84.13%-1.45M
-38.72%-2.94M
-62.46%-995.28K
0.04%-354.38K
-27.95%-802.8K
-50.10%-785.89K
-64,478.20%-2.12M
-612.63K
-354.54K
Net income continuous Operations
-73.18%-1.39M
-84.13%-1.45M
-38.72%-2.94M
-62.46%-995.28K
0.04%-354.38K
-27.95%-802.8K
-50.10%-785.89K
-64,478.20%-2.12M
---612.63K
---354.54K
Minority interest income
Net income attributable to the parent company
-73.18%-1.39M
-84.13%-1.45M
-38.72%-2.94M
-62.46%-995.28K
0.04%-354.38K
-27.95%-802.8K
-50.10%-785.89K
-64,478.20%-2.12M
-612.63K
-354.54K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-73.18%-1.39M
-84.13%-1.45M
-38.72%-2.94M
-62.46%-995.28K
0.04%-354.38K
-27.95%-802.8K
-50.10%-785.89K
-64,478.20%-2.12M
-612.63K
-354.54K
Basic earnings per share
-56.31%-0.21
-22.22%-0.22
-66.00%-0.6
-53.06%-0.16
11.11%-0.08
-25.49%-0.1344
-148.64%-0.18
-80,218.89%-0.3614
-0.1045
-0.09
Diluted earnings per share
-56.31%-0.21
-22.22%-0.22
-66.00%-0.6
-53.06%-0.16
11.11%-0.08
-25.49%-0.1344
-148.64%-0.18
-80,218.89%-0.3614
-0.1045
-0.09
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 101.14%1.97M47.46%1.75M-1.83%5.52M-10.15%1.77M4.45%1.58M-17.89%979.25K25.71%1.19M298.43%5.62M1.97M1.51M
Operating revenue 101.14%1.97M47.46%1.75M-1.83%5.52M-10.15%1.77M4.45%1.58M-17.89%979.25K25.71%1.19M298.43%5.62M--1.97M--1.51M
Cost of revenue 90.31%1.62M51.08%1.57M-9.94%4.1M-29.29%1.18M-6.67%1.03M-21.42%851.09K49.19%1.04M365.07%4.56M1.67M1.1M
Gross profit 173.10%350.01K21.83%179.29K32.97%1.41M100.05%582.04K34.01%554.54K16.97%128.16K-40.53%147.16K146.72%1.06M290.95K413.81K
Operating expense 90.81%1.74M76.13%1.62M36.43%4.3M75.87%1.57M18.01%897.56K24.70%912.11K20.04%921.63K626.76%3.15M891.7K760.6K
Selling and administrative expenses 60.60%1.45M46.52%1.33M29.02%4.01M50.35%1.32M17.74%885.2K23.12%899.82K18.56%909.87K646.59%3.11M--875.13K--751.85K
-Selling and marketing expense 1,469.83%13.89K1,669.39%15.38K--------------885--869------------
-General and administrative expense 59.21%1.43M44.97%1.32M29.02%4.01M50.35%1.32M17.74%885.2K23.00%898.94K18.45%909K646.59%3.11M--875.13K--751.85K
Research and development costs --277.89K--277.55K--240.05K----------0--0--0--------
Depreciation amortization depletion 41.33%17.37K6.65%12.55K228.45%48.77K22.87%12.36K218.48%12.36K1,962.58%12.29K3,634.29%11.76K7,073.43%14.85K--10.06K--3.88K
-Depreciation and amortization 41.33%17.37K6.65%12.55K228.45%48.77K22.87%12.36K218.48%12.36K1,962.58%12.29K3,634.29%11.76K7,073.43%14.85K--10.06K--3.88K
Other operating expenses ---------89.04%3.37K-99.23%50------------76.47%30.74K--6.51K--4.87K
Operating profit -77.35%-1.39M-86.44%-1.44M-38.18%-2.89M-64.15%-986.15K1.09%-343.02K-26.06%-783.95K-48.86%-774.48K-63,610.21%-2.09M-600.75K-346.79K
Net non-operating interest income expense 100.51%9772.88%-3.1K-78.24%-50.74K23.24%-9.12K-46.69%-11.36K-240.36%-18.85K-245.34%-11.42K-28.47K-11.88K-7.74K
Non-operating interest income 95,550.00%3.83K48,950.00%9814,569.84%2.94K1,188.89%1167,957.14%2.82K-78.95%4--2--63--9--35
Non-operating interest expense -80.22%3.73K-64.30%4.08K88.15%53.69K-22.33%9.24K82.29%14.18K239.27%18.85K245.40%11.42K--28.53K--11.89K--7.78K
Other net income (expense)
Income before tax -73.18%-1.39M-84.13%-1.45M-38.72%-2.94M-62.46%-995.28K0.04%-354.38K-27.95%-802.8K-50.10%-785.89K-64,478.20%-2.12M-612.63K-354.54K
Income tax
Net income -73.18%-1.39M-84.13%-1.45M-38.72%-2.94M-62.46%-995.28K0.04%-354.38K-27.95%-802.8K-50.10%-785.89K-64,478.20%-2.12M-612.63K-354.54K
Net income continuous Operations -73.18%-1.39M-84.13%-1.45M-38.72%-2.94M-62.46%-995.28K0.04%-354.38K-27.95%-802.8K-50.10%-785.89K-64,478.20%-2.12M---612.63K---354.54K
Minority interest income
Net income attributable to the parent company -73.18%-1.39M-84.13%-1.45M-38.72%-2.94M-62.46%-995.28K0.04%-354.38K-27.95%-802.8K-50.10%-785.89K-64,478.20%-2.12M-612.63K-354.54K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -73.18%-1.39M-84.13%-1.45M-38.72%-2.94M-62.46%-995.28K0.04%-354.38K-27.95%-802.8K-50.10%-785.89K-64,478.20%-2.12M-612.63K-354.54K
Basic earnings per share -56.31%-0.21-22.22%-0.22-66.00%-0.6-53.06%-0.1611.11%-0.08-25.49%-0.1344-148.64%-0.18-80,218.89%-0.3614-0.1045-0.09
Diluted earnings per share -56.31%-0.21-22.22%-0.22-66.00%-0.6-53.06%-0.1611.11%-0.08-25.49%-0.1344-148.64%-0.18-80,218.89%-0.3614-0.1045-0.09
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data